Blog

5 August 2024 - Strategic focus will reduce operating expenses with the goal of achieving Roctavian profitability by end of 2025. ...

7 August 2024 - The Centers for Medicare and Medicaid Services has finalised its rule easing reimbursement for medical device ...

29 July 2024 - With the addition of Alberta's public plan, Vascepa will be available to more than 90% of ...

27 June 2024 - Concerns have been raised about the relative effectiveness of an increasing number of new medicines at ...

26 June 2024 - The approval of Xpovio by the NHIS in South Korea is the fourth national reimbursement in the ...

19 April 2024 - A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, ...

1 April 2024 - Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate to severe plaque psoriasis in adults, ...

1 April 2024 - Merck Biopharma Korea's superovulation induction injection Pergoveris (follitropin alfa) will receive expanded reimbursement to treat patients ...

6 February 2024 - Public reimbursement for Vascepa is now available in Ontario, Quebec, British Columbia, Saskatchewan, New Brunswick, Northwest Territories, ...

17 January 2024 - 2023 was yet another dismal year for New Zealanders in terms of them being able to ...

11 January 2024 - Ono Pharmaceutical Korea said Thursday that Braftovi (encorafenib), a targeted therapy for BRAF V600E mutated metastatic ...

7 December 2023 - GSK's immunotherapy Jemperli (dostarlimab) is set to play a key role in the second-line treatment of ...

4 January 2024 - CVS Health said on Wednesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some ...

21 December 2023 - Merck and Eisai announce that Keytruda plus Lenvima, is now reimbursed with clinical criteria and conditions ...